Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Revenue projections:

Revenue projections for SUVENPHAR
Revenue projections for SUVENPHAR

SUVENPHAR's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 59.215343
debtToEquity 1.945000
earningsGrowth 0.755000
revenueGrowth 0.397000
grossMargins 0.627760
operatingMargins 0.316950
trailingEps 10.890000
forwardEps 0.000000

SUVENPHAR's high forward PE ratio indicates potential overvaluation, which could restrict future price growth and increase the risk of a correction. It's crucial to consider this metric in tandem with other fundamental data to fully assess the stock's outlook.
Suven Pharmaceuticals Limited's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that Suven Pharmaceuticals Limited is well-positioned for sustained growth in both profits and revenue.
SUVENPHAR's positive gross and operating margins indicate that the company is performing profitably. These margins reflect efficient cost control and revenue generation, signaling a strong financial foundation for continued success.

Price projections:

Price projections for SUVENPHAR
Price projections for SUVENPHAR

SUVENPHAR's price currently reflects projections without revealing significant risks or opportunities. This status quo implies that investors may experience minimal fluctuations in the stock, leading to a cautious approach in trading decisions until future indicators emerge.

Recommendation changes over time:

Recommendations trend for SUVENPHAR
Recommendations trend for SUVENPHAR


Analysts' recent buy bias toward Suven Pharmaceuticals Limited suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see Suven Pharmaceuticals Limited as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.